VEGFA and neoplasm: Angiogenesis inhibitors that generally block VEGF signaling exert their antitumor effects by disrupting tumor blood supply [3] and normalizing vascular structural abnormalities caused by excess VEGF, improving drug delivery and immune cell mobilization [4].